Dear Colleagues,
Vulvodynia is a vulvar discomfort that occurs in the absence of any specific, clinically identifiable disorder. Provoked vestibulodynia is the prevalent subtype of vulvodynia, and 12% of women are afflicted by this pathology at least once in their lifetime. Provoked vestibulodynia is a very common form of dyspareunia in both premenopausal and postmenopausal women, and is occasionally associated with other systemic diseases. It is a variegated, chronic pain condition of unspecified etiology. It has a significant impact on sexual activity and quality of life. Few therapies have shown to be effective for the treatment of vulvodynia. Technological and pharmacological innovations, have resulted in more precise and tailored therapy. This Special Issue will focus on the latest therapeutic strategies for this pathology.
Dr. Guglielmo Stabile
Guest Editor
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1500 USD. Submitted manuscripts should be well formatted in good English.